We fund and support research that could slow, stop or reverse Parkinson’s

Autumn Research Update Meeting 2025

Our next meeting will focus on multi-arm, multi-stage (MAMS) clinical trial platforms, an approach that is revolutionising Parkinson’s research. Attendees will hear presentations from two upcoming MAMS projects: EJS ACT-PD, a UK-based MAMS platform, and SLEIPNIR, a multi-arm clinical trial platform recently launched in Norway.

We’re here for the cure, and everything we do is to move us closer to that goal. We believe that collaboration between researchers, scientists, patients and funders is the key to accelerating promising treatments that will benefit people living with Parkinson’s.